Copyright
©2011 Baishideng Publishing Group Co.
World J Gastrointest Surg. Feb 27, 2011; 3(2): 21-28
Published online Feb 27, 2011. doi: 10.4240/wjgs.v3.i2.21
Published online Feb 27, 2011. doi: 10.4240/wjgs.v3.i2.21
NIH sponsored study in the USA[94] | 1. No AIDS-related opportunistic infections |
2. CD4 counts should be > 100/mL for those without a history of opportunistic infection and > 200/mL for those with a history of opportunistic infection. | |
3. HIV-RNA should be undetectable. In the event that an undetectable HIV viral load is not achievable as a result of drug-induced hepatotoxic, an HIV clinician should predict the ability to control the HIV virus post-transplantation. | |
Spanish criteria[41] | 1. No opportunistic infections |
2. CD4 counts > 100/mL | |
3. HIV-RNA should be undetectable or suppressible with antiretroviral therapy. | |
O’Grady[95] | 1. Absence of AIDS-defining illness after immune reconstitution |
2. CD4 counts should be > 200/mL or > 100/mL in the presence of portal hypertension. | |
3. Absence of HIV viremia | |
4. Antiretroviral therapeutic options available if the HIV disease reactivates |
- Citation: Sugawara Y, Tamura S, Kokudo N. Liver transplantation in HCV/HIV positive patients. World J Gastrointest Surg 2011; 3(2): 21-28
- URL: https://www.wjgnet.com/1948-9366/full/v3/i2/21.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v3.i2.21